Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion type Assertion NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_head.
- NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion description "[The genetic contribution to the development of ALL is examined by association studies that analyze the loci of Phase I enzymes (cytochrome P-450, myeloperoxidase) and Phase II enzymes (quinone-oxidoreductase, glutathione-S-transferase, N-acetyltransferase).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_provenance.
- NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion evidence source_evidence_literature NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_provenance.
- NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion SIO_000772 12041882 NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_provenance.
- NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion wasDerivedFrom befree-2016 NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_provenance.
- NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_assertion wasGeneratedBy ECO_0000203 NP356648.RAlB2cF9r7lip2Myge2-S5r1KLLVN9Hm1NlVFhqSOyics130_provenance.